These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15612883)

  • 1. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
    Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
    Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
    Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
    Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cancer-prone case with a background of methylation of p16 tumor suppressor gene.
    Hibi K; Koike M; Nakayama H; Fujitake S; Kasai Y; Ito K; Akiyama S; Nakao A
    Clin Cancer Res; 2003 Mar; 9(3):1053-6. PubMed ID: 12631606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer.
    Ficorella C; Cannita K; Ricevuto E; Toniato E; Fusco C; Sinopoli NT; De Galitiis F; Di Rocco ZC; Porzio G; Frati L; Gulino A; Martinotti S; Marchetti P
    Oncol Rep; 2003; 10(1):169-73. PubMed ID: 12469165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
    Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas.
    Huang MJ; Yeh KT; Shih HC; Wang YF; Lin TH; Chang JY; Shih MC; Chang JG
    Int J Mol Med; 2002 Nov; 10(5):551-4. PubMed ID: 12373290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
    Tokugawa T; Sugihara H; Tani T; Hattori T
    Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
    Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
    Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships among chromosome aneuploidy, promoter hypermethylation, and protein expression of the CDKN2A gene in individuals from northern Brazil with gastric adenocarcinoma.
    Guimarães AC; Lima EM; Khayat AS; Girão Faria MH; Barem Rabenhorst SH; Pitombeira MV; Assumpção PP; de Oliveira Bahia M; Lima de Lima PD; de Arruda Cardoso Smith M; Burbano RR
    Cancer Genet Cytogenet; 2007 Nov; 179(1):45-51. PubMed ID: 17981214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
    Hayashi K; Metzger R; Salonga D; Danenberg K; Leichman LP; Fink U; Sendler A; Kelsen D; Schwartz GK; Groshen S; Lenz HJ; Danenberg PV
    Oncogene; 1997 Sep; 15(12):1481-8. PubMed ID: 9333024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
    Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G
    Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway.
    Mino A; Onoda N; Yashiro M; Aya M; Fujiwara I; Kubo N; Sawada T; Ohira M; Kato Y; Hirakawa K
    Oncol Rep; 2006 Mar; 15(3):615-20. PubMed ID: 16465421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.